Helicobacter pylori (H. pylori)
infection and
cytokine-mediated inflammatory responses play important roles in
gastric cancer (GC) pathogenesis. To investigate an association between genetic polymorphisms in
interleukin (IL)-1β, IL-4R,
IL-8,
IL-10,
IL-16, IL-18RAP,
IL-22, and IL-32 and risks of GC and its precursors, a population-based study was conducted in Linqu County. Genotypes were determined by Sequenom MassARRAY platform in 132 GC cases and 1198 subjects with gastric lesions. The H. pylori status was determined by (13)C-urea breath test ((13)C-UBT) or
enzyme-linked
immunosorbent assay (ELISA). Among 11 candidate single nucleotide polymorphisms (SNPs), subjects carrying IL-18RAP rs917997 AA genotype were associated with risk of GC [adjusted odds ratio (OR) = 1.83, 95 % confidence interval (CI) 1.14-2.92] or chronic
atrophic gastritis (CAG; OR = 1.55, 95 % CI 1.07-2.24). The risk of GC was also increased in subjects carrying IL-32 rs2015620 A allele (AA + AT; OR = 1.92, 95 % CI 1.09-3.39). Moreover, elevated risks of CAG (OR = 2.64, 95 % CI 1.89-3.69), intestinal
metaplasia (IM; OR = 5.58, 95 % CI 3.86-8.05), and dysplasia (DYS; OR = 1.64, 95 % CI 1.18-2.26) were observed in subjects with
IL-22 rs1179251 CC genotype. Stratified analysis indicated that risks of GC and its precursors were elevated in subjects with IL-32 rs2015620 A allele (AA + AT) or
IL-22 rs1179251 CC genotype and H. pylori
infection, and significant interactions between these two SNPs and H. pylori
infection were found. These findings suggested that IL-18RAP rs917997, IL-32 rs2015620,
IL-22 rs1179251, and interactions between these polymorphisms and H. pylori
infection were associated with risks of gastric lesions. Genetic polymorphisms of
interleukins may play crucial roles in H. pylori-induced gastric
carcinogenesis.